I Xpress Genes Appoints John Schmitt As Chief Executive Officer (CEO) and Announces Nationwide Launch of Trauma Autoimmune Indicator (Tai) Test
Dec 16, 2024•7 months ago
Position
Chief Executive Officer
Company
iXpressGenes
Description
iXpressGenes (iXG) proudly appoints co-founder John Schmitt as Chief Executive Officer (CEO) and announces the nationwide launch of its Trauma Autoimmune Indicator (TAI) test, available by Q2 2025.
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months